American Thyroid Association surveys patients for satisfaction levels on treatment for hypothyroidism May 7, 2018—In…
Read More
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for…
ATA supports dialogue on the international harmonization of radiological emergency preparedness around nuclear power stations…
DIAGNOSED AND TREATED FOR THYROID CANCER? ATA® INVITES YOUR FEEDBACK ON THIS SURVEY: https://www.surveymonkey.com/r/thyroidcancerpatientsurvey The…
Hypothyroidism is the most common form of thyroid malfunctions, affecting up to 15 percent of…
New Rochelle, NY, December 14, 2017—A 10-year study of more than 1,200 patients with low-risk…
December 11, 2017—Dr. Megan R. Haymart, Associate Professor of Medicine at the University of Michigan,…
American Thyroid Association’s 2017 Van Meter Award Lecture Delivered by Megan R. Haymart, MD The…
American Thyroid Association: Charles H. Emerson, MD, Will Lead New Board of Directors October 19,…
American Thyroid Association’s 2017 Stanbury Medal to Be Awarded to James A. Fagin, MD The…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.